药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dacarbazine
Rupatadine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Rupatadine.
Dacarbazine
Lacidipine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Lacidipine.
Dacarbazine
Aranidipine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Aranidipine.
Dacarbazine
Pinaverium
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Pinaverium.
Dacarbazine
Trimebutine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Trimebutine.
Dacarbazine
Levocetirizine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Levocetirizine.
Dacarbazine
Solifenacin
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Solifenacin.
Dacarbazine
Perhexiline
The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Dasatinib.
Dacarbazine
Tolterodine
The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Dasatinib.
Dacarbazine
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Dasatinib.
Dacarbazine
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Dasatinib.
Dacarbazine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Fleroxacin.
Dacarbazine
Inotersen
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Inotersen.
Dacarbazine
Piromidic acid
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Piromidic acid.
Dacarbazine
Lorajmine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Lorajmine.
Dacarbazine
Prajmaline
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Prajmaline.
Dacarbazine
Cibenzoline
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Cibenzoline.
Dacarbazine
Cicletanine
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Cicletanine.
Dacarbazine
Pilsicainide
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Pilsicainide.
Dacarbazine
Givinostat
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Givinostat.